Huntington Ingalls Industries (NYSE:HII) Issues Quarterly Earnings Results, Beats Estimates By $0.11 EPS

Share on StockTwits

Huntington Ingalls Industries (NYSE:HII) posted its quarterly earnings results on Thursday. The aerospace company reported $3.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.63 by $0.11, Briefing.com reports. The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.20 billion. Huntington Ingalls Industries had a net margin of 8.04% and a return on equity of 42.07%. The firm’s revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the firm posted $5.29 EPS.

HII traded up $0.76 on Friday, hitting $251.21. The company had a trading volume of 450,488 shares, compared to its average volume of 312,075. The firm has a market cap of $9.56 billion, a P/E ratio of 13.16 and a beta of 1.19. Huntington Ingalls Industries has a 1 year low of $173.80 and a 1 year high of $254.14. The company’s fifty day moving average price is $216.46 and its 200 day moving average price is $216.34. The company has a current ratio of 1.12, a quick ratio of 1.05 and a debt-to-equity ratio of 1.15.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be issued a $1.03 dividend. This is a positive change from Huntington Ingalls Industries’s previous quarterly dividend of $0.86. This represents a $4.12 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 27th. Huntington Ingalls Industries’s payout ratio is 18.02%.

Several research analysts recently commented on HII shares. Bank of America reduced their price target on shares of Huntington Ingalls Industries from $305.00 to $275.00 and set a “buy” rating on the stock in a research note on Tuesday, August 6th. ValuEngine raised shares of Huntington Ingalls Industries from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Alembic Global Advisors raised shares of Huntington Ingalls Industries from a “neutral” rating to an “overweight” rating in a research note on Monday, August 5th. UBS Group raised their price target on shares of Huntington Ingalls Industries from $275.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Buckingham Research reduced their price target on shares of Huntington Ingalls Industries from $295.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $249.30.

In related news, VP Jerri F. Dickseski sold 1,874 shares of the business’s stock in a transaction dated Tuesday, October 8th. The shares were sold at an average price of $205.00, for a total value of $384,170.00. Following the sale, the vice president now directly owns 33,888 shares in the company, valued at approximately $6,947,040. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.65% of the stock is currently owned by insiders.

Huntington Ingalls Industries Company Profile

Huntington Ingalls Industries, Inc engages in the designing, building, overhauling, and repairing military ships in the United States. It operates through three segments: Ingalls Shipbuilding, Newport News Shipbuilding, and Technical Solutions. The company is involved in the design and construction of non-nuclear ships comprising amphibious assault ships that include deck amphibious ships and transport dock ships; surface combatants; and national security cutters for the U.S.

See Also: Back-End Load

Earnings History for Huntington Ingalls Industries (NYSE:HII)

Receive News & Ratings for Huntington Ingalls Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntington Ingalls Industries and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.